FDA SaMD

This white paper includes proposed Regulatory Framework for Modifications to AI/ML-based SaMD.

AAIH is an international multi-stakeholder advocacy organization based in Washington, D.C. that promotes scientific, legislative, and regulatory initiatives necessary to facilitate the development of, access to, and implementation of artificial intelligence (AI) powered healthcare solutions.

Previous
Previous

Comments to NIST Public Draft: US Leadership in AI

Next
Next

Standing Up the Alliance for AI in Healthcare